XXII Stock Quote
Company Report
22nd Century Group, Inc. is an innovative agricultural biotechnology company dedicated to advancing tobacco harm reduction and promoting health and wellness through cutting-edge plant science. Founded in 1998 and based in Buffalo, New York, the company focuses on developing very low nicotine content tobacco and cigarettes, marketed under the VLN King and VLN Menthol King brands. These products are designed to support tobacco harm reduction efforts by offering consumers a reduced nicotine alternative.
In addition to its tobacco-related innovations, 22nd Century Group is actively engaged in plant biotechnology across various sectors. The company collaborates with Keygene N.V. to develop hemp and cannabis plants with unique cannabinoid profiles and superior agronomic traits. This partnership aims to leverage advanced genetic technologies for medical, therapeutic, and agricultural applications, catering to evolving market demands and regulatory landscapes.
Furthermore, 22nd Century Group produces SPECTRUM research cigarettes, specifically formulated for independent clinical studies. These cigarettes play a crucial role in supporting scientific research initiatives focused on understanding the effects of nicotine and tobacco use on human health. With a commitment to scientific rigor and innovation, 22nd Century Group continues to drive progress in agricultural biotechnology, shaping the future of plant-based solutions for both the life sciences and consumer products industries.
XXII EPS Chart
XXII Revenue Chart